Benzinga’s Top Pre-Market Gainers (IMMU, POZN, ONXX, TASR, SQNM)
Immunomedics, Inc (NASDAQ: IMMU) jumped 5.00% to $ $3.78 in the pre-market session. Immunomedics has developed a novel protein complex for the targeted delivery of small interfering ribonucleic acids (siRNAs) to several types of cancers.
Pozen, Inc (NASDAQ: POZN) gained 2.74% to $10.50 in the pre-market session. POZN develops pharmaceutical products for the treatment of acute and chronic pain and other pain-related conditions.
ONYX Pharmaceuticals, Inc (NASDAQ: ONXX) added 2.42% to $30.86 in pre-market trading. Researchers, who were helping advanced lung cancer patients fare better by matching their tumors to targeted drugs, said that ONXX’s Nexavar delivered the best results.
TASER International, Inc. (NASDAQ: TASR) climbed 2.30% to $5.33 in pre-market trade. TASR has received ordered for 250 TASER X26 units.
Sequenom, Inc (NASDAQ: SQNM) moved up 1.72% to $5.90 in pre-market trading. SQNM has introduced the MassARRAY Analyzer 4 System.
Read more from Benzinga's Markets.
